ReviewCancer chemotherapy and pharmacology2025
Potential anticancer effects of sodium-glucose cotransporter protein 2 (SGLT2) inhibitors Canagliflozin and Dapagliflozin.
Weiyu Dong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it